Log in to save to my catalogue

IN/I-[1,3-Dialkyl Ligands; Insights into the Mechanism of Receptor Activation/Deactivation

IN/I-[1,3-Dialkyl Ligands; Insights into the Mechanism of Receptor Activation/Deactivation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A745964691

IN/I-[1,3-Dialkyl Ligands; Insights into the Mechanism of Receptor Activation/Deactivation

About this item

Full title

IN/I-[1,3-Dialkyl Ligands; Insights into the Mechanism of Receptor Activation/Deactivation

Publisher

MDPI AG

Journal title

Molecules (Basel, Switzerland), 2022-11, Vol.27 (23)

Language

English

Formats

Publication information

Publisher

MDPI AG

More information

Scope and Contents

Contents

Cannabinoid type 1 (hCB1) and type 2 (hCB2) receptors are pleiotropic and crucial targets whose signaling contributes to physiological homeostasis and its restoration after injury. Being predominantly expressed in peripheral tissues, hCB2R represents a safer therapeutic target than hCB1R, which is highly expressed in the brain, where it regulates p...

Alternative Titles

Full title

IN/I-[1,3-Dialkyl Ligands; Insights into the Mechanism of Receptor Activation/Deactivation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A745964691

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A745964691

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules27238152

How to access this item